Related Experiment Video
Updated: Jun 27, 2026
07:40
Gene Transfection toward Spheroid Cells on Micropatterned Culture Plates for Genetically-modified Cell Transplantation
Published on: July 31, 2015
8.8K
Spherical nucleic acids: emerging amplifiers for therapeutic nanoplatforms.
Zhenghao Tao1, Haitao Zhang1, Shang Wu1
1Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, University of South China, 421001, Hengyang, P. R. China. zhanghaitao@usc.edu.cn.
Nanoscale
|January 30, 2024
Summary
Spherical nucleic acids (SNAs) offer a novel solution for scalable gene therapy, overcoming challenges in gene delivery. This review highlights SNAs
Area of Science:
- Biotechnology
- Molecular Biology
- Nanotechnology
Background:
- Gene therapy holds promise but faces challenges in gene delivery efficacy due to inherent gene properties and vector defects.
- Enhancing gene drug efficacy and ensuring safer, more efficient utilization are critical for advancing gene therapy.
Purpose of the Study:
- To explore the amplifying contributions of spherical nucleic acids (SNAs) in gene therapy.
- To emphasize SNAs' role in enhancing gene therapy effects through structure, application, and clinical translation.
Main Methods:
- Review of fundamental characteristics and scaling-up properties of SNAs compared to linear nucleic acids.
- Analysis of combined therapy, theranostics, and clinical translation strategies amplified by SNAs.
Main Results:
- SNAs possess unique physicochemical properties making them suitable for scalable gene therapy.
- SNAs demonstrate potential in enhancing combined therapies, theranostics, and clinical applications.
Conclusions:
- SNAs represent an innovative solution for overcoming gene delivery challenges in gene therapy.
- Further research into SNAs' clinical translation and amplification characteristics is warranted to advance gene therapy.
